T9	Effect 67 89	inflammatory arthritis
T10	Treatment 105 123	receiving IFN-beta
T8	Subject 45 54;90 104	six cases in MS patients
T12	Population 45 48	six
T14	Drug 115 123	IFN-beta
T15	Treat-Disorder 93 95	MS
T11	Adverse_event 58 63	onset
E1	Adverse_event:T11